<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[9, 15] early-stage diabetic nephropathy patients<br>[60, 67] Type 2 diabetic patients (N.=57)<br>[89, 92] Diabetic nephropathy patients<br>[258, 263] type 2 diabetes mellitus patients<br></td>
<td width=33%>
[9, 21] early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy.<br>[60, 67] Type 2 diabetic patients (N.=57)<br>[89, 92] Diabetic nephropathy patients<br>[258, 263] type 2 diabetes mellitus patients<br></td>
<td width=33%>
[9, 21] early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy.<br>[60, 67] Type 2 diabetic patients (N.=57)<br>[89, 92] Diabetic nephropathy patients<br>[164, 168] diabetic group with nephropathy<br>[184, 188] diabetic group without nephropathy<br>[258, 266] type 2 diabetes mellitus patients "with nephropathy<br>[275, 280] patients with nephropathy treated with<br></td>
</tr>
